AAP
AMRI

Ardsley Advisory Partners’s Albany Molecular Research Inc AMRI Stock Holding History

Ardsley Advisory Partners’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-10,000
Closed -$163K – 268
2014
Q4 		$163K Buy
+10,000
New +$184K 0.03% 172

Other funds holding AMRI

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Ardsley Advisory Partners's AMRI Position: Q1 2015 in Review

Ardsley Advisory Partners sold out of Albany Molecular Research Inc (AMRI) in Q1 2015, closing a stake of 10,000 shares — an estimated $163K sold.

Ardsley Advisory Partners first reported a position in AMRI in Q4 2014 and held it in 1 quarter. The position peaked at $163K in Q4 2014. 131 funds tracked by Wall St. Rank hold AMRI as of Q1 2015.

  • Ardsley Advisory Partners reported no remaining Albany Molecular Research Inc position as of Q1 2015 after selling out during the quarter.
  • Ardsley Advisory Partners sold 10,000 Albany Molecular Research Inc shares in Q1 2015, an estimated $163K.
  • Ardsley Advisory Partners first reported a position in Albany Molecular Research Inc in Q4 2014 and held it in 1 quarter.
  • Ardsley Advisory Partners's Albany Molecular Research Inc position peaked at $163K in Q4 2014.
  • 131 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q1 2015.

Based on Ardsley Advisory Partners's 13F filing for Q1 2015, filed 15 May 2015.